EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Longitudinal changes in [18F]FDG PET brain metabolism as a prognostic marker in autoimmune encephalitis

Denise Cerne, Stefano Raffa, Giulia Benvenuto, Giacomo Rebella, Pietro Mattioli, Giacomo Bavestrello, Anastasia Lechiara, Emanuela Maria Mobilia, Dario Arnaldi, Flavio Villani, Luca Roccatagliata, Giampaola Pesce und 5 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2026-01 · 53 (2) · 1183-1197

DOI: 10.1007/s00259-025-07526-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 25.08.2025. Verfasst von Denise Cerne und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Encephalitis, Brain, Positron-Emission Tomography. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Genova.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Recent advancements in autoimmune encephalitis (AE) have enhanced diagnosis and management, but predicting long-term outcomes remains challenging. This study aims to evaluate longitudinal changes in brain [ 18 F]FDG PET patterns in AE patients to identify specific regional metabolic variations and predict clinical outcomes.

Methods

This longitudinal study compared brain [ 18 F]FDG PET scans of 22 AE patients at baseline (BS) and after treatment follow-up (FU) using voxel-wise paired t-tests. Significant clusters with at least 100 voxels and p < 0.05 were identified and designated as volumes of interest (VOIs). The VOI values were correlated with main clinical outcomes using partial Spearman’s tests, and their prognostic significance was assessed through regression models.

Results

Three VOIs showed significant metabolic changes between baseline (BS) and follow-up (FU) assessments. VOI-A, which was relatively hypermetabolic at BS, included the caudate-thalamus-parahippocampal region, right amygdala, and anterior cingulate cortex. VOI-B1 and VOI-B2, relatively hypometabolic at BS, corresponded to the right fusiform gyrus, precuneus, and temporo-parietal cortex, respectively. Poorer metabolic recovery in all VOIs to normalcy correlated with greater disability (mRS) in both acute and post-therapy phases. Lower metabolism in BS VOI-B1 predicted higher Clinical Assessment Scale in Autoimmune Encephalitis (CASE) score at FU and relapses, while lower age was a significant predictor of escalation to second-line treatment.

Conclusions

Longitudinal [ 18 F]FDG PET reveals distinct regional metabolic changes paralleling clinical recovery post-treatment in AE. Temporo-parietal metabolism correlates with relapses, clinical severity, and functional impairment, highlighting [ 18 F]FDG PET as a biological tracker of disease activity throughout AE and its prognostic value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18EncephalitisBrainPositron-Emission TomographyHashimoto DiseaseHumansFemaleMaleLongitudinal StudiesMiddle AgedAdultPrognosisAgedYoung AdultBiomarkers

Stichwörter der Autor:innen

Autoimmune encephalitisBiomarkersFDG-PETPrognosis

Substanzen

Fluorodeoxyglucose F18Biomarkers

Autor:innen und Institutionen

  • Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
  • IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Autoimmunology Laboratory, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
  • Department of Medical Sciences, University of Turin, Turin, Italy.
  • Nuclear Medicine Unit, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.

ORCID-Profile: Federico Massa

Förderung

  • Università degli Studi di Genova

Zitieren

APA

Cerne, D., Raffa, S., Benvenuto, G., Rebella, G., Mattioli, P., Bavestrello, G., Lechiara, A., Mobilia, E. M., Arnaldi, D., Villani, F., Roccatagliata, L., Pesce, G., Pardini, M., Morbelli, S., Uccelli, A., Benedetti, L., & Massa, F. (2026). Longitudinal changes in [18F]FDG PET brain metabolism as a prognostic marker in autoimmune encephalitis. European Journal of Nuclear Medicine and Molecular Imaging, 53(2), 1183-1197. https://doi.org/10.1007/s00259-025-07526-2

Vancouver

Cerne D, Raffa S, Benvenuto G, Rebella G, Mattioli P, Bavestrello G, et al. Longitudinal changes in [18F]FDG PET brain metabolism as a prognostic marker in autoimmune encephalitis. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(2):1183-1197. doi:10.1007/s00259-025-07526-2

BibTeX
@article{Cerne2026,
  author = {Cerne, Denise and Raffa, Stefano and Benvenuto, Giulia and Rebella, Giacomo and Mattioli, Pietro and Bavestrello, Giacomo and Lechiara, Anastasia and Mobilia, Emanuela Maria and Arnaldi, Dario and Villani, Flavio and Roccatagliata, Luca and Pesce, Giampaola and Pardini, Matteo and Morbelli, Silvia and Uccelli, Antonio and Benedetti, Luana and Massa, Federico},
  title = {Longitudinal changes in [18F]FDG PET brain metabolism as a prognostic marker in autoimmune encephalitis},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {2},
  pages = {1183--1197},
  doi = {10.1007/s00259-025-07526-2}
}
Kostenlos starten →